# Home biofeedback (VibroGait) for people with impaired somatosensation

> **NIH NIH R44** · APDM, INC. · 2020 · $249,149

## Abstract

Project Summary
Impaired somatosensation or impaired use of somatosensation by the nervous system is one of the most common
causes of balance and walking disability in older individuals. The human balance and gait control systems rely
on somatosensory information from foot contact with the support surface during walking. Somatosensory loss is
common with diabetes, normal aging, stroke, and with impaired central processing in neurological disorders such
as Parkinson's disease (PD), multiple sclerosis, and ataxia. Impaired somatosensation results in increased risk of
falls and is a major contributor to disability and death. In the absence of successful treatments to restore intrinsic
sensory feedback, we focus on using extrinsic (augmented) sensory feedback to provide complementary sensory
cueing to augment the patient's impaired sensory system. Feedback is a type of augmented feedback that provides
real-time cueing to improve motor control and help close the broken sensory-motor control loop.
This Fast-Track SBIR will allow APDM to prepare VibroGait for a commercial launch as the first wireless, gait
vibrotactile feedback system to be used during daily life. Specifically, we will develop a smart garment instrumented
with an inertial sensing unit and a microcontroller to wirelessly communicate with a tactor housed in a smart
silicone band to deliver vibrotactile stimulus to a desired body segment where there is adequate somatosensation to
perceive the vibratory cues. This standalone system will be a↵ordable to patients as well as easy to use and to turn
o↵ when not needed. VibroGait can also be plugged into APDM's advanced Mobility Lab, which uses sophisticated
and validated gait algorithms and a cloud database, to enable clinical researchers to monitor mobility impairments
and compliance of use of VibroGait. This project has two main aims. Our technology development aim is to
prepare VibroGait for clinical practice and FDA 510(k) clearance to clinical market. Our clinical research aim is
to demonstrate the clinical utility and e↵ectiveness of VibroGait in improving quality of mobility at home.

## Key facts

- **NIH application ID:** 10011639
- **Project number:** 1R44AG071250-01A1
- **Recipient organization:** APDM, INC.
- **Principal Investigator:** Mahmoud El-Gohary
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $249,149
- **Award type:** 1
- **Project period:** 2020-09-30 → 2020-10-01

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10011639

## Citation

> US National Institutes of Health, RePORTER application 10011639, Home biofeedback (VibroGait) for people with impaired somatosensation (1R44AG071250-01A1). Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/grant/nih/10011639. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*